<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The function EPsProg23() calculates the expected probability of a successful program
in a time-to-event setting. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:
If both trials are successful, no third phase III trial will be conducted.
If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (ymin).
The third trial then has to be significant at level alpha
If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.

"><title>Expected probability of a successful program deciding between two or three phase III trials in a time-to-event setting — EPsProg23 • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Expected probability of a successful program deciding between two or three phase III trials in a time-to-event setting — EPsProg23"><meta property="og:description" content="The function EPsProg23() calculates the expected probability of a successful program
in a time-to-event setting. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:
If both trials are successful, no third phase III trial will be conducted.
If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (ymin).
The third trial then has to be significant at level alpha
If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.

"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.1</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a>
    <a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a>
    <div class="dropdown-divider"></div>
    <a class="dropdown-item" href="../articles/index.html">More articles...</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Expected probability of a successful program deciding between two or three phase III trials in a time-to-event setting</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/functions_multitrial.R" class="external-link"><code>R/functions_multitrial.R</code></a></small>
      <div class="d-none name"><code>EPsProg23.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The function <code>EPsProg23()</code> calculates the expected probability of a successful program
in a time-to-event setting. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:</p><ul><li><p>If both trials are successful, no third phase III trial will be conducted.</p></li>
<li><p>If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (<code>ymin</code>).
The third trial then has to be significant at level <code>alpha</code></p></li>
<li><p>If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.</p></li>
</ul></div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">EPsProg23</span><span class="op">(</span><span class="va">HRgo</span>, <span class="va">d2</span>, <span class="va">alpha</span>, <span class="va">beta</span>, <span class="va">w</span>, <span class="va">hr1</span>, <span class="va">hr2</span>, <span class="va">id1</span>, <span class="va">id2</span>, <span class="va">case</span>, <span class="va">size</span>, <span class="va">ymin</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>HRgo</dt>
<dd><p>threshold value for the go/no-go decision rule</p></dd>


<dt>d2</dt>
<dd><p>total number of events in phase II</p></dd>


<dt>alpha</dt>
<dd><p>significance level</p></dd>


<dt>beta</dt>
<dd><p><code>1-beta</code> power for calculation of sample size for phase III</p></dd>


<dt>w</dt>
<dd><p>weight for mixture prior distribution</p></dd>


<dt>hr1</dt>
<dd><p>first assumed true treatment effect on HR scale for prior distribution</p></dd>


<dt>hr2</dt>
<dd><p>second assumed true treatment effect on HR scale for prior distribution</p></dd>


<dt>id1</dt>
<dd><p>amount of information for <code>hr1</code> in terms of number of events</p></dd>


<dt>id2</dt>
<dd><p>amount of information for <code>hr2</code> in terms of number of events</p></dd>


<dt>case</dt>
<dd><p>choose case: "at least 1, 2 or 3 significant trials needed for approval"</p></dd>


<dt>size</dt>
<dd><p>size category <code>"small"</code>, <code>"medium"</code> or <code>"large"</code></p></dd>


<dt>ymin</dt>
<dd><p>assumed minimal clinical relevant effect</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>The output of the function <code>EPsProg23()</code> is the expected probability of a successful program.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">res</span> <span class="op">&lt;-</span> <span class="fu">EPsProg23</span><span class="op">(</span>HRgo <span class="op">=</span> <span class="fl">0.8</span>, d2 <span class="op">=</span> <span class="fl">50</span>,  alpha <span class="op">=</span> <span class="fl">0.025</span>, beta <span class="op">=</span> <span class="fl">0.1</span>, </span></span>
<span class="r-in"><span>                                  w <span class="op">=</span> <span class="fl">0.3</span>, hr1 <span class="op">=</span>  <span class="fl">0.69</span>, hr2 <span class="op">=</span> <span class="fl">0.81</span>, </span></span>
<span class="r-in"><span>                                  id1 <span class="op">=</span> <span class="fl">280</span>, id2 <span class="op">=</span> <span class="fl">420</span>, case <span class="op">=</span> <span class="fl">2</span>, size <span class="op">=</span> <span class="st">"small"</span>,</span></span>
<span class="r-in"><span>                                  ymin <span class="op">=</span> <span class="fl">0.5</span><span class="op">)</span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Stella Erdmann, Johannes Cepicka, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

